---
category: news
title: "Debiopharm International SA: DEBIOPHARM INVESTS IN VERISIM LIFE'S $15M SERIES A ROUND TO ADVANCE AI-ENABLED DRUG RESEARCH"
excerpt: "Funding to support BIOiSIM computational platform to reduce the need for animal testing by selecting compounds showing promise to cure a disease prior to research in humans LAUSANNE, Switzerland"
publishedDateTime: 2022-01-10T18:29:00Z
originalUrl: "https://www.finanznachrichten.de/nachrichten-2022-01/54935953-debiopharm-international-sa-debiopharm-invests-in-verisim-life-s-dollar-15m-series-a-round-to-advance-ai-enabled-drug-research-008.htm"
webUrl: "https://www.finanznachrichten.de/nachrichten-2022-01/54935953-debiopharm-international-sa-debiopharm-invests-in-verisim-life-s-dollar-15m-series-a-round-to-advance-ai-enabled-drug-research-008.htm"
type: article
quality: 0
heat: -1
published: false

provider:
  name: Finanznachrichten
  domain: finanznachrichten.de

topics:
  - AI

related:
  - title: "DEBIOPHARM INVESTS IN VERISIM LIFE'S $15M SERIES A ROUND TO ADVANCE AI-ENABLED DRUG RESEARCH"
    excerpt: "Debiopharm (  ), a Swiss biopharmaceutical company, announced today their co-investment in California -based start-up VeriSIM Life's $15 Million Series A Round to advance their mission to accelerate drug development via technology powered by artificial intelligence (AI)."
    publishedDateTime: 2022-01-10T18:35:00Z
    webUrl: "https://www.tmcnet.com/usubmit/-debiopharm-invests-verisim-lifes-15m-series-round-advance-/2022/01/10/9523113.htm"
    type: article
    provider:
      name: TMCnet
      domain: tmcnet.com
    quality: 6

secured: "auPUDnvjzix4VhVUfvCn6abLPwRGF/03/n5XAHLgFEeCt6WnSw57DtnrwkgKYfiCnmq2LV3JpLPJMsHL0w+yJvhEwk0NpxL3R7sdhJbLJ1tll9osgrngVkp3F+vdEzi07GyJ8KziBYBuwJsiYL99CO2Y7U91IY/C0WSTuQ4LV5QG2Y1ZUtILT0T5sCnYpEk/nmY9Sfws2LMoJNlFSb+E8boJERXb3jlSMSwR6SY1204gkK/Kku8bAgG5MUhm5oPFCh6SkqBtPZSDWk1+8sZq4g5INPHiO+afB7Re/7FoUzVXhg8qQBBu73Cj9BuEmgEtsdC8YiT9pgSSKV+oU/hgco0Fg+s4D4v/5c+87WEaZ78=;eae9OQVnt53p/hpMg4Hq3w=="
---

